Don't miss SGLT Tools - PowerPoint slide library for SGLT2 inhibitors

Is Loop Diuretic Use in End Stage Renal Disease Really Safe? No-Diuretics versus Diuretics for Euvolemia in Hemodialysis Trial

In order to vote and see your remaining funds, please log in here
Current total funding for this study: $226,600

Author:

John Wigneswaran
Nephrologist

Study Acronym:

NO DUH Trial

NO DUH Trial is a three arm, double blind, placebo control, multi-center trial. Incident dialysis patients with at least 360 mL of urine a day are randomized to:

  1. Placebo
  2. Diuretic 1: Furosemide at 80 mg twice a day but then titrated up to maximize urine output (up to 500 mg per day) without going below a doctor established “dry weight”. Investigators would be encouraged to keep these patients euvolemic based on clinical judgment.
  3. Diuretic 2: Furosemide at 80 mg twice a day with no adjustment for urine output or renal function.

Patients would be randomized to the three arms at a 2:1:1 ratio so that half of the patients receive diuretics and then the two different diuretic strategies would be tested.

Outcomes:

  • Time until first hospitalizations (could be surrogate for mortality)
  • Number of hospitalizations and length of stay
  • Quality of life
  • Intradialytic weight gain
  • Residual renal output
  • Neurohormonal measures (Renin, Aldosterone, Endothelin-1, Catecholamines)
  • Blood pressure (Number of medications, dosage)
  • Echocardiogram (Baseline, 1 year)

Comments (0)

There are no comments posted here yet

Leave your comments

  1. Posting comment as a guest. Sign up or login to your account.
Attachments (0 / 3)
Share Your Location
ukidneyisup